Bosley Katrine 4
4 · Editas Medicine, Inc. · Filed Sep 6, 2018
Insider Transaction Report
Form 4
Bosley Katrine
DirectorPresident and CEO10% Owner
Transactions
- Sale
Common Stock
2018-09-04$32.27/sh−10,787$348,096→ 1,254,179 total - Sale
Common Stock
2018-09-04$33.07/sh−1,213$40,114→ 1,252,966 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2017, as amended.
- [F2]This transaction was executed in multiple trades at prices ranging from $31.79 to $32.78. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $32.79 to $33.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.